Skip to main content
SpringerLink
Log in

Krankheitsmodifizierende Antikörpertherapie gegen Amyloid

Wirkt Aducanumab bei Alzheimer?

  • Journal club
  • Published:
InFo Neurologie + Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenzen

  1. Morar U et al. Alzheimers Dement 2022; 14: e12258

  2. Lagarde J et al. J Neurol Neurosurg Psychiatry 2022; jnnp-2021-328623

  3. Cummings J, Salloway S. Alzheimers Dement 2021; 10.1002/alz.12444

Download references

Author information

Authors and Affiliations

  1. Klinik für Neurologie, Klinikum Bremen-Ost, Züricher Straße 40, 28325, Bremen, Germany

    Thomas Duning

Authors
  1. Thomas Duning
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Duning.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duning, T. Wirkt Aducanumab bei Alzheimer?. InFo Neurologie 24, 29–30 (2022). https://doi.org/10.1007/s15005-022-2324-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-022-2324-2

Search

Navigation